Taxotere® is also sold under the generic name of Docetaxel. Taxotere is a cancer chemotherapy drug that works by helping to block the growth of cancerous cells in the human body. It is often prescribed for the treatment of lung, breast, prostate, head, neck and stomach cancer.
This medication is injected through an I.V. typically once every three weeks and is often used in combination with other cancer drugs.
The FDA approved Taxotere in 1999 after a series of clinical trials. The agency found that the drug created some adverse effects that included anemia, temporary alopecia (loss of hair), esophagitis, and nausea. Taxotere is manufactured by Sanofi-Aventis®.
More than three million women have been diagnosed with breast cancer in the U.S. and it is estimated that 75 percent of these patients have taken Taxotere. In 2010, sales of Taxotere exceeded $3.1 billion in the U.S. alone.
Common Taxotere Side Effects
As with many cancer medications, Taxotere has some side effects that range from the mild to the severe to the deadly, including:
- Red skin rash
- Difficult in breathing
- Lower red blood cell count
- Severe fluid retention
- Vision problems
- Low platelets in the blood (causes bruising, severe bleeding and red spots under skin)
- Liver problems (dark urine, jaundice, upper stomach pain)
- Congestive heart failure
Taxotere Hair Loss Legal Problems
Over the past several years, a number of women have discovered that after taking Taxotere, they suffered permanent hair loss.
Some of these women have filed lawsuits against Sanofi-Aventis accusing the drug manufacturer of not fully disclosing the fact that Taxotere could cause permanent hair loss. The accusers claim this is much more emotionally and psychologically damaging to women than to men.
The issue is that the makers of Taxotere failed to tell patients that their hair loss would be permanent, but instead told patients that their hair would grow back after treatment ended.
What makes things worse, is that the permanent hair loss suffered by hundreds of cancer patients occurred throughout their entire body, including eyelashes and eyebrows.
Some of the lawsuits claim that Sanofi-Aventis had commissioned internal studies that revealed this permanent hair loss but hid this fact from the public, knowing that it would cause negative publicity.
Filing a Claim With Taxotere Lawyers
We recognize what a devastating psychological and emotional effect permanent hair loss can have for a woman. That’s why we are prepared to offer our services to any cancer patient who has suffered as a result of Taxotere. With more than 20 years of experience, we can evaluate your situation to determine if legal action is warranted against Sanofi-Aventis./p>